9 stories for Hepatitis Awareness Month
Click Here to Manage Email Alerts
May is Hepatitis Awareness Month in the United States, and May 19 is Hepatitis Testing Day.
To raise awareness of the “hidden” viral hepatitis epidemic, the CDC offers free resources on its website, including a feature on the “ABCs” of the three most common types of viral hepatitis in the U.S.
To mark the occasion, we prepared a list of nine stories related to viral hepatitis.
COVID-19 pandemic led to decreases in hepatitis C testing, treatment
New research suggests that the pandemic caused declines in hepatitis C testing and treatment, which may hurt efforts to meet 2030 WHO goals. Read more.
One-time universal screening for hepatitis B could save 23K lives, nearly $600 million
A one-time universal screening for hepatitis B could prevent 23,000 additional deaths from HBV-related liver disease. Read more.
First patient dosed in a phase 2 combined therapy trial for chronic HBV
The first patient has been dosed in a trial exploring combination therapy for patients with chronic HBV infection. Read more.
Three-antigen HBV vaccine produces high seroprotection rates in adults
A three-antigen hepatitis B vaccine candidate showed significantly better seroprotection in adults when compared with a monovalent vaccine. Read more.
Hepatitis B vaccine shows promise in patients on hemodialysis
Another hepatitis B vaccine showed seroprotection in nearly 90% of patients on hemodialysis. Read more.
Novel models of care allow expansion of HCV treatment
Specialists are attempting to widen the base of clinicians caring for patients with hepatitis C by using novel models of care. Read more.
Q&A: Diagnosing new HCV infections more challenging during COVID-19 pandemic
Healio spoke with Sunil S. Solomon, MBBS, from the Johns Hopkins School of Medicine, about the pandemic’s impact on hepatitis C research. Read more.
HBV antiviral treatment linked with reduced cirrhosis risk
Patients with chronic hepatitis B who received antiviral therapy showed a significant reduction in risk for cirrhosis. Read more.
Current liver cancer screening protocols may miss at-risk Black individuals with HCV
Black patients with hepatitis C had more aggressive hepatocellular carcinoma tumors than other racial groups despite having better liver function at the time of diagnosis. Read more.